Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To study the impact of intra and post-operative Terlipressin infusion on the occurrence of acute kidney injury after LDLT To investigate perioperative Neutrophil Gelatinase Associated Lipocalin (NGAL) changes and study the effect of Terlipressin on NGAL blood levels

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Liver Institute, Egypt
• Collaborators: Dr. Ayman Alsebaey Qotb Alghoraieb.; Dr. Khaled Ahmed Yassen; Dr. Khalid Mousa Abouelenain; Dr. Mohamed Abdelrauf kandil; Dr. Mohamed Helmi Ibrahim Afifi
• Treatments: Lypressin; Terlipressin

Criteria

Inclusion Criteria:

• Adult living donor liver transplant recipients with no preoperative renal dysfunction

Exclusion Criteria:

• patients with renal insufficiency defined as serum creatinine > 2 mg/dl and GFR <60 ml/min by isotope scanning of the kidney.